FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Guide on ANDA Pre-Submission Facility Correspondence

FDA posts a final guidance entitled ANDAs: Pre-Submission Facility Correspondence (PFC) Related to Prioritized Generic Drug Submissions.

latest-news-card-1
Marketing

Senators Introduce Bill to Ban DTC Drug Advertising

Senators Bernie Sanders (I-VT) and Angus King (I-ME) introduce legislation that would ban direct-to-consumer drug advertising.

latest-news-card-1
Biologics

Oncologic Panel to Review Multiple Myeloma BLA

FDA schedules a 7/17 meeting of its Oncologic Drugs Advisory Committee to review and vote on a GSK BLA for Blenrep (belantamab mafodotin) for treating...

latest-news-card-1
Medical Devices

Medtronic Newport Ventilator Recall Class 1

FDA says a Medtronic recall of specified Newport ventilators is Class 1.

Biologics

Questions Raised on New ACIP Members

The Associated Press reports that questions are being raised about some new members appointed to the CDC Advisory Committee on Immunization Practices ...

latest-news-card-1
Human Drugs

Capricor Gets Form-483 After BLA Facility Inspection

A recent FDA pre-license inspection of Capricor Therapeutics San Diego manufacturing facility for investigation cell therapy Deramiocel results in a F...

latest-news-card-1
Human Drugs

FDA Approves UroGen Bladder Cancer Therapy

FDA approves a UroGen Pharma NDA for Zusduri (mitomycin intravesical solution) for adult patients with recurrent low-grade intermediate-risk non-muscl...

Medical Devices

Viz.ai Subdural Hemorrhage Quantifier Cleared

FDA clears a Viz.ai 510(k) for the Viz Subdural Plus, which the company describes as the first and only comprehensive solution for quantifying the siz...

Animal Drugs

Researchers Challenge FDA Lamictal Safety Warning

Rutgers University researchers say they have determined that the GlaxoSmithKline anti-seizure drug Lamictal is safe for adults with epilepsy and conco...

latest-news-card-1
FDA General

More FDA Operational Changes Coming: Makary

Saying that operational consolidations are coming in support services, FDA commissioner Martin Makary asks the staff to view change with openness and ...